These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18478580)

  • 1. Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach.
    Grazioso G; Cavalli A; De Amici M; Recanatini M; De Micheli C
    J Comput Chem; 2008 Nov; 29(15):2593-602. PubMed ID: 18478580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
    Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into docking and scoring neuronal alpha4beta2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations.
    Sgrignani J; Bonaccini C; Grazioso G; Chioccioli M; Cavalli A; Gratteri P
    J Comput Chem; 2009 Nov; 30(15):2443-54. PubMed ID: 19360794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
    Bunnelle WH; Tietje KR; Frost JM; Peters D; Ji J; Li T; Scanio MJ; Shi L; Anderson DJ; Dyhring T; Grønlien JH; Ween H; Thorin-Hagene K; Meyer MD
    J Med Chem; 2009 Jul; 52(14):4126-41. PubMed ID: 19552432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.
    Enz A; Feuerbach D; Frederiksen MU; Gentsch C; Hurth K; Müller W; Nozulak J; Roy BL
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1287-91. PubMed ID: 19208472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding.
    Huang X; Zheng F; Stokes C; Papke RL; Zhan CG
    J Med Chem; 2008 Oct; 51(20):6293-302. PubMed ID: 18826295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.
    Chen SG; Gu RX; Dai H; Wei DQ
    J Mol Graph Model; 2013 Feb; 39():98-107. PubMed ID: 23261879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling differential binding of alpha4beta2 nicotinic acetylcholine receptor with agonists and antagonists.
    Huang X; Zheng F; Zhan CG
    J Am Chem Soc; 2008 Dec; 130(49):16691-6. PubMed ID: 19554732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of alpha-conotoxin binding modes on neuronal nicotinic acetylcholine receptors.
    Dutertre S; Nicke A; Tyndall JD; Lewis RJ
    J Mol Recognit; 2004; 17(4):339-47. PubMed ID: 15227641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer modeling of binding of diverse weak toxins to nicotinic acetylcholine receptors.
    Mordvitsev DY; Polyak YL; Kuzmin DA; Levtsova OV; Tourleigh YV; Utkin YN; Shaitan KV; Tsetlin VI
    Comput Biol Chem; 2007 Apr; 31(2):72-81. PubMed ID: 17392029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New spirocyclic Δ²-isoxazoline derivatives related to selective agonists of α7 neuronal nicotinic acetylcholine receptors.
    Dallanoce C; Frigerio F; Grazioso G; Matera C; Visconti GL; De Amici M; Pucci L; Pistillo F; Fucile S; Gotti C; Clementi F; De Micheli C
    Eur J Med Chem; 2011 Dec; 46(12):5790-9. PubMed ID: 22014558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
    Dallanoce C; Magrone P; Matera C; Frigerio F; Grazioso G; De Amici M; Fucile S; Piccari V; Frydenvang K; Pucci L; Gotti C; Clementi F; De Micheli C
    ChemMedChem; 2011 May; 6(5):889-903. PubMed ID: 21365765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
    Tsetlin V; Utkin Y; Kasheverov I
    Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
    Papke RL; Schiff HC; Jack BA; Horenstein NA
    Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.
    Stoica I; Sadiq SK; Coveney PV
    J Am Chem Soc; 2008 Feb; 130(8):2639-48. PubMed ID: 18225901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calculated cation-pi binding energies to predict relative strengths of nicotinic acetylcholine receptor agonists.
    Tantama M; Licht S
    ACS Chem Biol; 2008 Nov; 3(11):693-702. PubMed ID: 19032090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.